O-GlcNAcase uses substrate-assisted catalysis Kinetic analysis and development of highly selective mechanism-inspired inhibitors

• Author(s) / Creator(s)

  • Vocadlo, David J.
  • Whitworth, Garrett E.
  • Macauley, Matthew S.
  • Debowski, Aleksandra W.
  • Chin, Danielle

• The post-translational modification of serine and threonine residues of nucleocytoplasmic proteins with 2-acetamido-2-deoxy-d-glucopyranose (GlcNAc) is a reversible process implicated in multiple cellular processes. The enzyme O-GlcNAcase catalyzes the cleavage of β-O-linked GlcNAc (O-GlcNAc) from modified proteins and is a member of the family 84 glycoside hydrolases. The family 20 β-hexosaminidases bear no apparent sequence similarity yet are functionally related to O-GlcNAcase because both enzymes cleave terminal GlcNAc residues from glycoconjugates. Lysosomal β-hexosaminidase is known to use substrate-assisted catalysis involving the 2-acetamido group of the substrate; however, the catalytic mechanism of human O-GlcNAcase is unknown. By using a series of 4-methylumbelliferyl 2-deoxy-2-N-fluoroacetyl-β-d-glucopyranoside substrates, Taft-like linear free energy analyses of these enzymes indicates that O-GlcNAcase uses a catalytic mechanism involving anchimeric assistance. Consistent with this proposal, 1,2-dideoxy-2′-methyl-α-d-glucopyranoso-[2,1-d]-Δ2′-thiazoline, an inhibitor that mimics the oxazoline intermediate proposed in the catalytic mechanism of family 20 glycoside hydrolases, is shown to act as a potent competitive inhibitor of both O-GlcNAcase (KII = 0.070 μm) and β-hexosaminidase (K = 0.070 μm). A series of 1,2-dideoxy-2′-methyl-α-d-glucopyranoso-[2,1-d]-Δ2′-thiazoline analogues were prepared, and one inhibitor demonstrated a remarkable 1500-fold selectivity for O-GlcNAcase (KI = 0.230 μm) over β-hexosaminidase (KI = 340 μm). These inhibitors are cell permeable and modulate the activity of O-GlcNAcase in tissue culture. Because both enzymes have vital roles in organismal health, these potent and selective inhibitors of O-GlcNAcase should prove useful in studying the role of this enzyme at the organismal level without generating a complex chemical phenotype stemming from concomitant inhibition of β-hexosaminidase.

• Date created

  2005

• Subjects / Keywords

  • Crystal-Structure
  • Tay-Sachs-Disease
  • Nucleocytoplasmic Proteins
  • Insulin-Resistance
  • Linked N-Acetylglucosamine
  • Diabetogenic Action
  • Cytosolic Proteins
  • Beta-D-Glucosaminidase
  • Glycosyl Hydrolases
  • Alzheimers-Disease

• Type of Item

  Article (Published)

• DOI

  https://doi.org/10.7939/R3PN8XW0G

• License

  © 2005 Matthew S. Macauley et al. This version of this article is open access and can be downloaded and shared. The original author(s) and source must be cited.